Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients.
BACKGROUND The effect of clopidogrel monotherapy as compared with extended dual antiplatelet therapy (DAPT) with clopidogrel and aspirin beyond 12 months after implantation of a drug-eluting stent remains uncertain in patients at high risk for recurrent ischemic events. METHODS In this open-label noninferiority trial...